From pharmacy to innovation hub: Why India needs a regulatory revolution in biotech

India aims to transition from a global pharmacy to an innovation hub by reforming its regulatory landscape. The focus is on AI-powered approvals, adaptive trials, fast-track pathways, and a single-window digital platform. Creating public market access for biotech startups and incentivizing investment are crucial to compete with China's advancements in drug innovation.